These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 13066241

  • 1. [Results of triethylene melanine therapy of Hodgkin's disease and of chronic myeloid leukemia; preliminary communication].
    GARCIGA CE.
    Arch Cuba Cancerol; 1953; 12(1-6):39-46. PubMed ID: 13066241
    [No Abstract] [Full Text] [Related]

  • 2. The clinical use of triethylene melamine.
    KRAVITZ SC, DIAMOND HD, CRAVER LF.
    Blood; 1952 Jul; 7(7):729-42. PubMed ID: 14934758
    [No Abstract] [Full Text] [Related]

  • 3. Myleran and triethylene melamine in the treatment of chronic granulocytic leukemia.
    BETHELL FH.
    Ann N Y Acad Sci; 1958 Apr 24; 68(3):996-1000. PubMed ID: 13627746
    [No Abstract] [Full Text] [Related]

  • 4. Unusual toxicity to triethylene melamine in a case of chronic myelogenous leukemia.
    SLIPYAN A.
    Ann Intern Med; 1953 Feb 24; 38(2):331-5. PubMed ID: 13017443
    [No Abstract] [Full Text] [Related]

  • 5. TRIETHYLENE-MELAMINE.
    Br Med J; 1955 Jun 04; 1(4926):1380-1. PubMed ID: 14363905
    [No Abstract] [Full Text] [Related]

  • 6. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
    NEUMANN C.
    Klin Wochenschr; 1952 Dec 15; 30(47-48):1105-8. PubMed ID: 13023980
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of hemoblastosis with triethylene melamine].
    LINKE A, LASCH HG.
    Dtsch Med Wochenschr; 1953 Jun 19; 78(25):911-6. PubMed ID: 13068032
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of lymphomatous diseases with triethylene melamine.
    MEYER LM, SCHWARTZ SO, SAWITSKY A, BEYERS MR, RITZ ND, BRAHIN C, DIEFENBACH W, KLEINSCHMIDT W, FRIEDMAN I.
    Acta Med Scand Suppl; 1952 Jun 19; 272():1-36. PubMed ID: 13039963
    [No Abstract] [Full Text] [Related]

  • 9. TRIETHYLENE MELAMINE IN THE CONTROL OF HODGKIN'S DISEASE AND THE LEUKEMIAS. IV. CLINICAL REPORTS, 1959-62.
    SAMPEY JR.
    Am J Pharm Sci Support Public Health; 1963 Dec 19; 135():451-7. PubMed ID: 14101404
    [No Abstract] [Full Text] [Related]

  • 10. Observations on the use of triethylene melamine in Hodgkin's disease.
    DE ANDINO AM, ROMERO C, RIVERA J, RODRIGUEZ-MOLINA R.
    Bol Asoc Med P R; 1953 Apr 19; 45(4):107-18. PubMed ID: 13066528
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma].
    HAEHNER E, HEINEN W, LOOSEN H, SCHMIDT H.
    Med Klin; 1954 May 21; 49(21):853-4; passim. PubMed ID: 13164965
    [No Abstract] [Full Text] [Related]

  • 12. [Triethylene melamine in Hodgkin's disease].
    HOST H, QVIGSTAD G.
    Nord Med; 1955 Sep 08; 54(36):1383-5. PubMed ID: 13266133
    [No Abstract] [Full Text] [Related]

  • 13. Triethylene melamine in the treatment of neoplastic disease.
    RUNDLES RW, BARTON WB.
    Blood; 1952 May 08; 7(5):483-507. PubMed ID: 14925143
    [No Abstract] [Full Text] [Related]

  • 14. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
    HAMBLY CK, ROBERTSON TI.
    Med J Aust; 1955 Jun 18; 42(1 25):900-11. PubMed ID: 13243982
    [No Abstract] [Full Text] [Related]

  • 15. [Immediate results of triethylene melamine therapy of neoplastic diseases].
    LENTI G, GAVOSTO F.
    Minerva Med; 1953 Jan 06; 44(1-2):1-19. PubMed ID: 13054386
    [No Abstract] [Full Text] [Related]

  • 16. Triethylene melamine in the treatment of Hodgkin's disease and other lymphomas.
    ROTTINO A.
    N Y State J Med; 1952 Feb 01; 52(3):346-8. PubMed ID: 14899689
    [No Abstract] [Full Text] [Related]

  • 17. Triethylene melamine therapy in Hodgkin's and other malignant diseases.
    HANSEN PB, BICHEL J.
    Acta Radiol (Stockh); 1951 Dec 01; 36(6):469-76. PubMed ID: 14902588
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of Hodgkin's disease with triethylene melamine; preliminary report].
    BOLIO MONSREAL E.
    Bol Liga Contra Cancer Havana; 1953 Jun 01; 28(3):56-62. PubMed ID: 13115509
    [No Abstract] [Full Text] [Related]

  • 19. [The therapeutic effect of triethylene melamine in hemoblastosis].
    SCHULZE E, FRANKE R, THIELE FH.
    Arztl Wochensch; 1953 Jul 17; 8(29):690-4. PubMed ID: 13080055
    [No Abstract] [Full Text] [Related]

  • 20. [Triethylene melamine therapy of malignant granulomatosis and certain other malignant diseases].
    HANSEN PB, BICHEL J.
    Nord Med; 1952 Jan 11; 47(2):58-61. PubMed ID: 14910945
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.